Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed November 8, 2022. Open the filing →
- Filed
- Nov 8, 2022, 2:06 PM EST
- Fiscal quarter
- Q3 FY2022
- Calendar quarter
- Q3 2022
- Accession
- 0001558370-22-016818
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s EBITDA?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported EBITDA of -$43.93M in Q3 2021.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude